SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biomatrix (BXM) Looking Great
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike Relyea who wrote (411)2/28/1998 1:00:00 PM
From: John McCarthy   of 569
 
Mike -

I have a terrible ERROR in my reply to you.

As Jon Nunley noted in the following post .....

Message 3514561

and has James Baker advised me ...

ANIK *will not* have to go thru an advisory panel.

To me, that means they are out the door with product
in the USA no later than July 1.

Others on the ANIK thread have commented about the potential
price of ANIK. To me, that is totally tied into the size
of the O/A market. (I am pushing anti-adhesion in the
background just to limit this conversation)

At a later date I will post my numbers about this market.

In any event, ANIK under $30.00 a share, to me, is a steal.

Please recall that there are only about 8.5 mil. shares out.
And as the market gets wind of whats going on, for a time,
PE ratios don't matter.

Regards,

John McCarthy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News